ROCKET LAB CORP (RKLB) Stock Fundamental Analysis

NASDAQ:RKLB • US7731211089

70.2 USD
+0.23 (+0.33%)
At close: Feb 25, 2026
70.28 USD
+0.08 (+0.11%)
After Hours: 2/25/2026, 7:31:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, RKLB scores 3 out of 10 in our fundamental rating. RKLB was compared to 74 industry peers in the Aerospace & Defense industry. While RKLB seems to be doing ok healthwise, there are quite some concerns on its profitability. RKLB is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • RKLB had negative earnings in the past year.
  • In the past year RKLB has reported a negative cash flow from operations.
  • In the past 5 years RKLB always reported negative net income.
  • In the past 5 years RKLB always reported negative operating cash flow.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • RKLB has a Return On Assets of -8.90%. This is in the lower half of the industry: RKLB underperforms 67.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -15.43%, RKLB is doing worse than 64.86% of the companies in the same industry.
Industry RankSector Rank
ROA -8.9%
ROE -15.43%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • RKLB has a better Gross Margin (31.70%) than 71.62% of its industry peers.
  • The Profit Margin and Operating Margin are not available for RKLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RKLB has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for RKLB has been increased compared to 5 years ago.
  • Compared to 1 year ago, RKLB has a worse debt to assets ratio.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • RKLB has an Altman-Z score of 23.64. This indicates that RKLB is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 23.64, RKLB belongs to the best of the industry, outperforming 95.95% of the companies in the same industry.
  • A Debt/Equity ratio of 0.32 indicates that RKLB is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.32, RKLB is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 23.64
ROIC/WACCN/A
WACC9.64%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • RKLB has a Current Ratio of 3.18. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of RKLB (3.18) is better than 67.57% of its industry peers.
  • RKLB has a Quick Ratio of 2.83. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
  • RKLB has a Quick ratio of 2.83. This is in the better half of the industry: RKLB outperforms 77.03% of its industry peers.
Industry RankSector Rank
Current Ratio 3.18
Quick Ratio 2.83
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • RKLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.70%.
  • The Revenue has grown by 52.42% in the past year. This is a very strong growth!
  • RKLB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.23% yearly.
EPS 1Y (TTM)-2.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)52.42%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%47.97%

3.2 Future

  • RKLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.40% yearly.
  • Based on estimates for the next years, RKLB will show a very strong growth in Revenue. The Revenue will grow by 34.45% on average per year.
EPS Next Y-4%
EPS Next 2Y18.87%
EPS Next 3Y31.99%
EPS Next 5Y32.4%
Revenue Next Year38.18%
Revenue Next 2Y43.88%
Revenue Next 3Y43.35%
Revenue Next 5Y34.45%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RKLB. In the last year negative earnings were reported.
  • Also next year RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • RKLB's earnings are expected to grow with 31.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.87%
EPS Next 3Y31.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for RKLB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ROCKET LAB CORP

NASDAQ:RKLB (2/25/2026, 7:31:34 PM)

After market: 70.28 +0.08 (+0.11%)

70.2

+0.23 (+0.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-10
Earnings (Next)02-26
Inst Owners57.76%
Inst Owner Change0.94%
Ins Owners0.73%
Ins Owner Change-4.8%
Market Cap37.50B
Revenue(TTM)554.53M
Net Income(TTM)-197.63M
Analysts80
Price Target85.59 (21.92%)
Short Float %7.17%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.22%
Min EPS beat(2)-11.38%
Max EPS beat(2)71.81%
EPS beat(4)3
Avg EPS beat(4)18.1%
Min EPS beat(4)-11.38%
Max EPS beat(4)71.81%
EPS beat(8)7
Avg EPS beat(8)15.56%
EPS beat(12)8
Avg EPS beat(12)9.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.41%
Min Revenue beat(2)0.19%
Max Revenue beat(2)4.63%
Revenue beat(4)2
Avg Revenue beat(4)0.8%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)4.63%
Revenue beat(8)3
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)-0.57%
Revenue beat(16)8
Avg Revenue beat(16)0.96%
PT rev (1m)20.9%
PT rev (3m)33.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.15%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)13.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 67.62
P/FCF N/A
P/OCF N/A
P/B 29.27
P/tB 45.11
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS1.04
BVpS2.4
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.9%
ROE -15.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.7%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 334.43%
Cap/Sales 23.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.18
Quick Ratio 2.83
Altman-Z 23.64
F-Score5
WACC9.64%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y-4%
EPS Next 2Y18.87%
EPS Next 3Y31.99%
EPS Next 5Y32.4%
Revenue 1Y (TTM)52.42%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%47.97%
Revenue Next Year38.18%
Revenue Next 2Y43.88%
Revenue Next 3Y43.35%
Revenue Next 5Y34.45%
EBIT growth 1Y-23.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.48%
EBIT Next 3Y42.86%
EBIT Next 5Y36.07%
FCF growth 1Y-71.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.74%
OCF growth 3YN/A
OCF growth 5YN/A

ROCKET LAB CORP / RKLB FAQ

Can you provide the ChartMill fundamental rating for ROCKET LAB CORP?

ChartMill assigns a fundamental rating of 3 / 10 to RKLB.


What is the valuation status for RKLB stock?

ChartMill assigns a valuation rating of 1 / 10 to ROCKET LAB CORP (RKLB). This can be considered as Overvalued.


How profitable is ROCKET LAB CORP (RKLB) stock?

ROCKET LAB CORP (RKLB) has a profitability rating of 1 / 10.


Can you provide the financial health for RKLB stock?

The financial health rating of ROCKET LAB CORP (RKLB) is 5 / 10.